PIK3CA Mutation
Oncology·MeSH: Breast Neoplasms
4 drugs in development·2 companies·4 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Capivasertib | Relay Therapeutics, Inc. (RLAY) |
Compare drugs
Frequently asked questions
How many drugs are in development for PIK3CA Mutation?
BioSniper tracks 4 drugs in development for PIK3CA Mutation across 2 companies.
How many clinical trials target PIK3CA Mutation?
There are 4 clinical trials targeting PIK3CA Mutation tracked by BioSniper.
Deep-dive into PIK3CA Mutation
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis